Kania I, Gospodarek E, Ulatowska B
Department of Microbiology, Medical University, ul. Skłodowskiej-Curie 9, 85-094 Bydgoszcz, Poland.
Med Sci Monit. 2000 Nov-Dec;6(6):1122-7.
Bacteria of Enterococcus spp. are now much more often isolated from various diagnostic materials in systemic infection, both in hospitalized and in ambulatory patients. The study included 571 enterococci strains isolated from urine in 1997. Species identification was performed by rapid ID32 STREP test (bioMérieux) for 327 analyzed strains. Enterococcus faecalis and Enterococcus faecium dominated (46.1% and 11.2%, respectively). Over 42% of strains were isolated from urine of patients with non-significant bacteriuria or as concomitant flora. In such cases, simplified identification was performed and the strains were determined as Enterococcus spp. The microorganisms analyzed originated primarily from the urine samples of patients hospitalized at the Department of Urology (41.8%), the Department of Neurology (11.9%) and the Department of Internal Medicine and Nephrology (9.9%). Enterococcus faecalis strains were second with respect to population count (263--10.6%), after Escherichia coli strains (464--18.8%), while Enterococcus faecium strains were the sixth (64--2.5%). Enterococcus genus took the first place among all microorganisms isolated from the urine samples. Antibiotic-sensitivity was determined for 323 enterococci strains originating from hospitalized and ambulatory patients. Enterococcus faecium strains, naturally resistant to beta-lactam antibiotics, were sensitive to nitrofuranoin in more than 50% and to norfloxacin in about 20%. Among 254 analyzed Enterococcus faecalis strains, 80.0% were sensitive to ampicillin, nitrofurantoin and high concentrations of gentamicin as well as streptomycin. Enterococci strains isolated from hospitalized patients proved sensitive to ampicillin and carbapenems in 76.8%, while strains isolated from ambulatory patients were 100% sensitive to these drugs. Examination of enterococci isolated from urine of patients hospitalized showed 33.8% sensitive to norfloxacin and 84.6% sensitive to nitrofurantoin. All the enterococci strains were sensitive to glycopeptide antibiotics: vancomycin, teicoplanin.
肠球菌属细菌现在更常从全身感染患者的各种诊断材料中分离出来,无论是住院患者还是门诊患者。该研究纳入了1997年从尿液中分离出的571株肠球菌菌株。对327株分析菌株采用快速ID32 STREP试验(生物梅里埃公司)进行菌种鉴定。粪肠球菌和屎肠球菌占主导地位(分别为46.1%和11.2%)。超过42%的菌株是从无意义菌尿患者的尿液中分离出来的,或作为伴随菌群。在这种情况下,进行了简化鉴定,并将菌株确定为肠球菌属。分析的微生物主要来自泌尿外科(41.8%)、神经科(11.9%)以及内科和肾内科(9.9%)住院患者的尿液样本。粪肠球菌菌株在数量上排第二(263株,占10.6%),仅次于大肠杆菌菌株(464株,占18.8%),而屎肠球菌菌株排第六(64株,占2.5%)。肠球菌属在从尿液样本中分离出的所有微生物中位居首位。对来自住院和门诊患者的323株肠球菌菌株进行了抗生素敏感性测定。屎肠球菌菌株天然对β-内酰胺类抗生素耐药,对呋喃妥因的敏感性超过50%,对诺氟沙星的敏感性约为20%。在254株分析的粪肠球菌菌株中,80.0%对氨苄西林、呋喃妥因以及高浓度庆大霉素和链霉素敏感。从住院患者中分离出的肠球菌菌株对氨苄西林和碳青霉烯类药物的敏感性为76.8%,而从门诊患者中分离出的菌株对这些药物的敏感性为100%。对住院患者尿液中分离出的肠球菌进行检测显示,对诺氟沙星的敏感性为33.8%,对呋喃妥因的敏感性为84.6%。所有肠球菌菌株对糖肽类抗生素万古霉素、替考拉宁敏感。